KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Profit After Tax (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Profit After Tax for 4 consecutive years, with -$211.7 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Profit After Tax fell 22.31% year-over-year to -$211.7 million, compared with a TTM value of -$892.9 million through Dec 2023, up 57.53%, and an annual FY2025 reading of -$312.8 million, up 42.83% over the prior year.
  • Profit After Tax was -$211.7 million for Q4 2023 at Ginkgo Bioworks Holdings, up from -$302.9 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$26.1 million in Q3 2020 and bottomed at -$1.6 billion in Q4 2021.
  • Average Profit After Tax over 4 years is -$366.3 million, with a median of -$208.3 million recorded in 2023.
  • The sharpest move saw Profit After Tax crashed 3353.39% in 2021, then surged 89.17% in 2022.
  • Year by year, Profit After Tax stood at -$46.3 million in 2020, then plummeted by 3353.39% to -$1.6 billion in 2021, then soared by 89.17% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023.
  • Business Quant data shows Profit After Tax for DNA at -$211.7 million in Q4 2023, -$302.9 million in Q3 2023, and -$173.3 million in Q2 2023.